Stock Screener App

Frei -

Installieren

10.18

0.15% 0.015

Drugs Made In America Acquisition Ii Corp (DMII)

Überblick Nachrichten Preisverlauf Forum Prognose

Drugs Made In America Acquisition Ii Corp Aktie (DMII) Neueste Nachrichten

Starton Therapeutics Appoints Experienced Finance Executive Saleem Elmasri, CPA, as Chief Financial Officer - The Manila Times

Layoff Tracker: TScan axes 75% of workforce, prioritizes solid tumor program - BioSpace

Eli Lilly and Co. | Pharmaceuticals, Biomedical Research, & Company - Britannica

Drugs Made In America Acquisition II (DMII) Holds at $10.15 as SPAC Shares Trade Flat Within RangeValue Area Low - dars.gov.et

RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring's Rebyota® and Clenpiq® - PR Newswire

Pfizer Inc. - Britannica

Drugs Made In America Acquisition (NASDAQ:DMAA) Shares Down 0%Should You Sell? - MarketBeat

Drugs (DMIIU) Momentum: Ends Little Changed at $10.20 in the Latest Reading; Immediate View: the Supplied Trading Band Runs From $9.69 to $10.71 under the Current SnapshotMomentum Breakout Ideas - siam.in

Drugs (DMII): Closes 0.20% Higher at $10.14 in Latest Trading; Chart Watch: $9.63 and $10.65 Define the Nearby Reference Levels in Latest TradingBuy Signal Reports - vinanet.vn

Drugs (DMII) Momentum: Ends Up by 0.10% at $10.13 in the Current Update; Current Setup: the Price Remains Bounded by the Supplied Support and Resistance in the Latest SessionMarket Neutral Pair - vinanet.vn

Drugs Made In America Acquisition Corp. (DMAA) Stock Price, Chart, News & Analysis - Securities.io

Drugs (DMIIR) Daily Review: Closes with Little Net Change at $0.10 in Latest Trading; Level-Based View: the Current Price Sits Inside the Supplied Technical Range at the CloseMerger Arbitrage - Vinanet

DMII Holds at $10.13: Drugs Made In America Acquisition II Corp. Trades Flat Amid SPAC Market ConsolidationAdvance Decline Volume - dars.gov.et

Drugs Made In America Acquisition II (DMII) Earnings Date and Reports 2026 - MarketBeat

DMII Holds Steady at $10.13 as Acquisition Vehicle Trades in Tight RangeGamma Exposure - vinanet.vn

Drugs Made In America II (DMII) earns $8.7M but warns on going concern - Stock Titan

Drugs Made In America Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Karpus Management (DMAA) discloses 10.33% beneficial stake in SPAC - Stock Titan

Drugs Made In America (DMAA): First Trust funds disclose 3.24% beneficial stake - Stock Titan

DMAA Holds at $10.69 as SPAC Awaits Definitive Acquisition TargetPCR Moving Average - vinanet.vn

Drugs Made In America Acquisition II Corp. (DMIIU) Holds Steady at $10.17 as SPAC Unit Trades in Tight RangeIchimoku Cloud - vinanet.vn

Glazer Capital (DMAA) discloses 4.12% beneficial stake in Drugs Made in America - Stock Titan

Mizuho Financial Group (DMAA) discloses 8.5% beneficial stake in SPAC - Stock Titan

Drugs Made In America Acquisition Corp (DMAA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

DMII Holds at $10.11: Drugs Made In America Acquisition II Shows Typical Pre-Deal StabilitySystematic Flow - Vinanet

Drugs Made In America Acquisition Corp (DMAA) Stock News Today - TradingKey

COPL|Copley Acquisition Corp|Price:10.480|Chg%:+0.010 - TradingKey

AstraZeneca falls to third-largest UK company amid US merger talks - The Guardian

DMAAR Rights Edge Up to $0.16 as Tight Range Between Support and Resistance PersistsVolume Oscillator - Vinanet

DMII Holds Steady at $10.12 as SPAC Trades Near Trust ValueDealer Positioning - Vinanet

ICU Medical Inc. (ICUI) Gains 2.67%: Approaching Key Resistance LevelsStatistical Arbitrage - Vinanet

DMII|Drugs Made In America Acquisition II Ord Shs|Price:10.105|Chg%:+0.005 - TradingKey

Drugs Made In America Acquisition II Ord Shs (DMII) Cash Flow - TradingKey

Drugs Made In America Acquisition II Corp. Revenue Breakdown – NASDAQ:DMIIR - TradingView

CAII|Collective Acquisition II Ord Shs Class A|Price:9.950|Chg%:+0.010 - TradingKey

Drugs Made In America Acquisition II Ord Shs (DMII) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Drugs Made In America Acquisition Corp (DMAA) Valuation: PE, PB & Fair Value Analysis - TradingKey

Drugs Made In America Acquisition Corp - TradingKey

Drugs Made In America Acquisition II Ord Shs (DMII) Institutional Confidence - TradingKey

162,795 Shares in Drugs Made In America Acquisition Corp. $DMAA Purchased by Sona Asset Management US LLC - MarketBeat

DMII|Drugs Made In America Acquisition II Ord Shs|Price:10.130|Chg%:+0.020 - TradingKey

DMII|Drugs Made In America Acquisition II Ord Shs|Price:10.140|Chg%:+0.040 - TradingKey

Drugs Made In America Acquisition II Ord Shs (DMII) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Drugs Made In America Acquisition II Ord Shs (DMII) Valuation: PE, PB & Fair Value Analysis - TradingKey

UAC|United Acquisition I Units|Price:9.930|Chg%:-0.010 - TradingKey

ALUB|Alussa Energy Acquisition II Ord Shs Class A|Price:10.120|Chg%:+0.010 - TradingKey

Drugs Made In America Acquisition II Ord Shs (DMII) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Drugs Made In America Acquisition II Ord Shs (DMII) Income Statement - TradingKey

Drugs Made In America Acquisition II Ord Shs (DMII) Balance Sheet - TradingKey

Drugs Made In America Acquisition Corp (DMAA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

BBCQ|Bleichroeder Acquisition II Units|Price:10.170| - TradingKey

Drugs Made In America Acquisition II Corp. Right (DMIIR) Rights See Modest Gain Amid Tight Trading RangeBPI Bear Confirmed - dars.gov.et

GSRV|GSR V Acquisition Ord Shs Class A|Price:9.890| - TradingKey

QETA|Quetta Acquisition Corp|Price:11.430| - TradingKey

BLUW|Blue Water Acquisition Corp III|Price:10.340|Chg%:+0.010 - TradingKey

IRAB|Iris Acquisition II Units|Price:10.000|Chg%:+0.020 - TradingKey

PAII|Pyrophyte Acquisition Corp II|Price:10.240|Chg%:-0.010 - TradingKey

DRDB|Roman DBDR Acquisition Corp II|Price:10.585|Chg%:-0.020 - TradingKey

Drugs Made In America Acquisition II Corp. Revenue Breakdown – NASDAQ:DMII - TradingView

APAC|StoneBridge Acquisition II Ord Shs Class A|Price:10.185|Chg%:-0.015 - TradingKey

CAPN|Cayson Acquisition Corp|Price:11.100|Chg%:-0.050 - TradingKey

ASPC|A SPAC III Acquisition Corp|Price:10.542|Chg%:-0.098 - TradingKey

TradingKey - TradingKey

LATA|Galata Acquisition Corp II|Price:10.150|Chg%:+0.020 - TradingKey

NWAX|New America Acquisition I Units|Price:10.170| - TradingKey

IQMX|IQM Quantum Computers Oyj American Depositary Shares|Price:9.438|Chg%:+0.333 - TradingKey

Drugs Made In America Acquisition Corp (DMAA) Balance Sheet - TradingKey

RIBB|RIBB|Price:10.810| - TradingKey

MSA Q1 2026 Earnings: EPS Beats Estimates by 7.95%, Stock Edges HigherPeak Earnings Alert - Vinanet

EVAC

$10.31

0.05%

BCSS

$10.29

0.10%

CXII

$10.75

0.19%

CEPF

$10.37

0.10%

AEXA

$11.47

1.66%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters